Dr. Setia is a surgical pathologist with a subspecialty focus in gastrointestinal pathology.
Massachusetts General Hospital/Harvard Medical School
Fellowship - Gastrointestional Pathology
2014
Baystate Medical Center/Tufts University School of Medicine
Fellowship - Cytopathology
2013
Brigham and Women's Hospital/Harvard Medical School
Boston
Fellowship - Surigal Pathology
2012
Baystate Medical Center/Tufts University School of Medicine
MD
2008
Maulana Azad Medical College
New Delhi, India
MD
2004
Lady Hardings Medical College
New Delhi, India
MBBS
1997
Clonal Relatedness Index: Practical and Reliable Tool for Establishing Clonal Relatedness in Gastrointestinal, Hepatopancreaticobiliary, and Peritoneal Carcinomas.
Clonal Relatedness Index: Practical and Reliable Tool for Establishing Clonal Relatedness in Gastrointestinal, Hepatopancreaticobiliary, and Peritoneal Carcinomas. J Mol Diagn. 2026 Sep 25.
PMID: 42790700
All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs.
All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs. Clin Lab Med. 2026 Sep; 46(3):577-606.
PMID: 42526975
ASO Visual Abstract: Survival Outcomes in Early-Onset Appendiceal Adenocarcinoma (EOAA).
ASO Visual Abstract: Survival Outcomes in Early-Onset Appendiceal Adenocarcinoma (EOAA). Ann Surg Oncol. 2026 Sep; 33(9):8565-8566.
PMID: 42289628
Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA).
Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA). Ann Surg Oncol. 2026 Sep; 33(9):8546-8554.
PMID: 42251206
Inflammatory adenoma-like hepatocellular neoplasm in cirrhotic livers.
Inflammatory adenoma-like hepatocellular neoplasm in cirrhotic livers. Histopathology. 2026 Jun; 88(7):1466-1469.
PMID: 41969142
Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas.
Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas. Cancer Med. 2026 Apr; 15(4):e71809.
PMID: 41968866
ASO Visual Abstract: Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma.
ASO Visual Abstract: Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2026 Apr; 33(4):3477-3478.
PMID: 41559464
Investigating Genetic Risk to Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Colorectal Cancer Through Routinely Available Next-Generation Sequencing Data.
Investigating Genetic Risk to Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Colorectal Cancer Through Routinely Available Next-Generation Sequencing Data. Mod Pathol. 2026 05; 39(5):100988.
PMID: 41786212
Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma.
Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2026 Apr; 33(4):3453-3461.
PMID: 41634519
Patterns of Gastrointestinal Injury Associated With CAR-T Therapy for Patients With Multiple Myeloma.
Patterns of Gastrointestinal Injury Associated With CAR-T Therapy for Patients With Multiple Myeloma. Am J Surg Pathol. 2026 03 01; 50(3):292-300.
PMID: 41372162